
HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ON FEBRUARY 21, 2023
PLYMOUTH MEETING, Pa., Feb. 7, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") HRMY, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare …